- Home
- SMTI vs MRVI Comparison
SMTI vs MRVI Comparison
Compare SMTI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- MRVI
- Stock Information
- Founded
- SMTI 1982
- MRVI 2014
- Country
- SMTI United States
- MRVI United States
- Employees
- SMTI N/A
- MRVI N/A
- Industry
- SMTI Medical/Dental Instruments
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- MRVI Health Care
- Exchange
- SMTI Nasdaq
- MRVI Nasdaq
- Market Cap
- SMTI 273.6M
- MRVI 312.4M
- IPO Year
- SMTI N/A
- MRVI 2020
- Fundamental
- Price
- SMTI $28.07
- MRVI $2.27
- Analyst Decision
- SMTI Strong Buy
- MRVI Hold
- Analyst Count
- SMTI 2
- MRVI 10
- Target Price
- SMTI $49.50
- MRVI $6.84
- AVG Volume (30 Days)
- SMTI 37.7K
- MRVI 1.6M
- Earning Date
- SMTI 08-11-2025
- MRVI 08-06-2025
- Dividend Yield
- SMTI N/A
- MRVI N/A
- EPS Growth
- SMTI N/A
- MRVI N/A
- EPS
- SMTI N/A
- MRVI N/A
- Revenue
- SMTI $91,569,883.00
- MRVI $241,856,000.00
- Revenue This Year
- SMTI $23.53
- MRVI N/A
- Revenue Next Year
- SMTI $5.93
- MRVI $10.62
- P/E Ratio
- SMTI N/A
- MRVI N/A
- Revenue Growth
- SMTI 34.65
- MRVI N/A
- 52 Week Low
- SMTI $25.86
- MRVI $1.67
- 52 Week High
- SMTI $39.08
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- SMTI 41.55
- MRVI 54.46
- Support Level
- SMTI $26.84
- MRVI $2.00
- Resistance Level
- SMTI $30.36
- MRVI $2.44
- Average True Range (ATR)
- SMTI 1.13
- MRVI 0.15
- MACD
- SMTI -0.01
- MRVI -0.00
- Stochastic Oscillator
- SMTI 34.94
- MRVI 61.36
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.